The convulsant opiate thebaine, an intermediate of morphine biosynthesis, was purified from ovine brain to homogeneity by gel filtration and high-performance liquid chromatography (HPLC) monitored by a radioimmunoassay. The immunoreactive material behaved identically to standard thebaine in two HPLC systems and was confirmed to be thebaine by combined gas chromatography/mass spectrometry. To our knowledge, the presence of thebaine in mammalian tissue has not been demonstrated previously. Codeine and morphine were also found to exist in ovine brain. The presence of thebaine in ovine brain provides strong evidence that morphine and codeine, in various mammalian tissues, are of endogenous origin and actually biosynthesized from a precursor.
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Recent evidence has focused attention on the existence of endogenous opiate alkaloids in mammalian tissues (1) (2) (3) . These molecules may then constitute a component of a unique regulatory pathway perhaps involving enkephalin, dynorphin, and endorphin, the more fully characterized opiate peptides. This notion is substantiated by the finding that the levels of two opiate alkaloids, morphine and codeine, are not static but rather undergo rapid alterations following physiological stimulation (3, 4) , whereas bioconversion of various opiate precursors can be demonstrated in vivo (1, 5) or in vitro (5, 6) . A critical issue is to establish whether any of these intermediates actually exists in brain and further to determine whether they have biological activity in their own right. We report here that one opiate, thebaine, a precursor in the biosynthesis of morphine and codeine that has convulsant properties, is present in ovine brain.
METHODS
Materials. Ovine brains (from Colorado Lamb, Denver, CO) were used for the isolation of endogenous opiate alkaloids. (-)-Thebaine (Hoffmann-La Roche) crystallized from methanol was used for radioimmunoassay (RIA), highperformance liquid chromatography (HPLC), and gas chromatography/mass spectrometry (GC/MS) analysis as a standard. (-)-Codeine was from Merck. Morphine hydrochloride and '25I-labeled morphine (90-150 Ci/mmol; 1 Ci = 37 GBq)
were from Hoffmann-La Roche. Other reagents were purchased from Baker or Sigma.
RIA. A rabbit antiserum that was raised against 3-carboxymethylmorphine conjugated to bovine serum albumin (7) and 1251-labeled morphine as tracer were used in the RIA. The sensitivity of the assay to thebaine [IC50 = 0.58 + 0.04 pmol (mean ± SEM)] is about 1/10th that of morphine or codeine, both of which react equally well with the antiserum (6). The detectiori limit of the assay for thebaine is 0.08 pmol. With this level of sensitivity we were able to detect a thebaine-like compound during the purification steps.
Extraction and Purification Procedures. For purification of thebaine-like immunoreactive (ir) compound from ovine brain, Iyophilized ovine brain (2000 g) was pulverized, defatted with two times 3 vol of methylene chloride, and dried. The defatted material was heated in 10 vol of 1 M acetic acid containing 10 mM HCl at 95-100'C for 10 min, cooled on ice, homogenized in a Polytron, and maintained at 40C overnight. The material was centrifuged (10,000 x g, 30 min) and the supernatant was subjected to ultrafiltration (Amicon YM-10) at 40C. The filtrate was Iyophilized.
Step I (Fig. lA) : Gel filtration at 40C on a 5.0 x 140 cm column of Sephadex G-50 equilibrated with 1 M acetic acid. One-fourth of the extract was reconstituted with 150 ml of the eluent, centrifuged, and applied to the column; flow rate was 15 ml/rnin and 15-ml fractions were collected. The effluent was monitored by UV absorbance at 280 nm (model 100-40 spectrophotometer, Hitachi). Of the total column volume, every 10 fractions were combined and lyophilized. This gel filtration procedure was repeated four times. To determine which fractions from Sephadex G-50 column contain morphinerelated ir substances, fractions were then applied to a Sephadex G-15 column. The following three low molecular weight fractions were found to have the ir substance: fractions 121-130, 38 g; 131-140, 44 g; 141-150, 29 g. Step 2 ( Fig.  1B) : Gel filtration on a 3.0 x 100 cm column of Sephadex G-15 equilibrated with 0.1 M pyridine/acetic acid, pH 4.7. Onefifth offractions 121-130, from step 1, was reconstituted with 10 ml of buffer and applied to the column; flow rate was 1.07 ml/min and 11-ml fractions were collected. The effluent was monitored by UV detector (model 153, Altex) at 254 nm. Aliquots of each fraction were dried (Savant Speed-Vac concentrator), reconstituted in Dulbecco's phosphate-buffered saline (pH 7.4), and assayed with a RIA for the opiate alkaloids. The ir fractions (bracket) from five successive runs were pooled and dried.
Step 3 ( Fig. 2 
716
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. RIA. The position of the ir peak was identical to that of standard thebaine (arrow). The fractions between 87 and 93 min were combined and evaporated to dryness.
Step 5 (Fig.  4) : The ir peak from step 4 was applied to the same RP18 column as in step 3 and eluted at 1.45 ml/min with 0.1 M pyridine/acetic acid, pH 4.7, containing 12% acetonitrile, giving a detectable EC response peak at 750 mV and an ir peak (total, 45 pmol). The ir peak, coeluted with standard thebaine (arrow), was evaporated to dryness and a portion (30 pmol) was used for GC/MS analysis. Portions of the HPLC solvent blank and standard thebaine that were passed through the reverse-phase HPLC system (Fig. 4) were also used for GC/MS analysis (see below). During the HPLC purification steps, standard thebaine, codeine, or morphine was assayed following each fractionation step. Following application of the standard, the injection system and the HPLC columns were washed with methanol and/or chloroform plus multiple injections of 30% acetic acid/methanol°E (vol/vol) or dimethyl sulfoxide to remove any standard retained in the system. After washing, immunoreactivity was not detected at the retention times of the standards.
GC/MS Procedure. The HPLC solvent blank at the retention time of thebaine, the putative thebaine from ovine brain (30 pmol), and standard thebaine (35 pmol), which were collected at step S in 
RESULTS
Thebaine-like ir compound was purified from an acetic acid-containing HCl extract of ovine brain by gel filtration, reverse-phase (RP18), and ion-exchange HPLC systems.
Fractions were assayed with a RIA to detect morphine- Figs. 1-4 show the purification procedures of thebaine-like ir compound from ovine brain. The ovine brain acid extract was first subjected to Sephadex G-50 filtration (Fig. lA) . The RIA was not performed at this stage because of the high concentration of acid in each fraction, which interfered with the assay. The low molecular weight material from the Sephadex G-50 filtration was applied to a Sephadex G-15 column, and a broad region of morphine-related ir compounds was found (Fig 1B) . Application of this ir fraction to a RP18 column resulted in two main ir peaks (Fig. 2) . The first peak was similar to the position where standard morphine and codeine eluted. Morphine and codeine cannot be separated using this solvent system. The second peak eluted in the same position as standard thebaine. The second peak was then applied to an ion-exchange column for further purification. It was found to have an identical retention time as that of standard thebaine (Fig. 3) . The thebaine-like ir peak was rechromatographed on the same RP18 column used in step 3 (Fig. 2) . A single EC response peak associated with immunoreactivity occurred where standard thebaine eluted (Fig. 4) . The total amount isolated was 45 pmol. Portions of this endogenous putative thebaine, and also standard thebaine and HPLC solvent blank collected at step 5 in Fig. 4 , were then subjected to GC/MS analysis (Fig. 5) . The electronionization mass spectrum of standard thebaine has a base peak corresponding to the molecular ion at m/z 311 and two major fragment ions at m/z 296 and m/z 255. These fragment ions result from loss of a methyl group and the N-methyl bridge with hydrogen transfer (C3H6N) (8) , respectively. Standard thebaine and the endogenous putative thebaine eluted at the same GC oven temperature (192°C) and retention time (16.2 min), and all three of the above diagnostic ions plus numerous other characteristic lower mass fragment ions occurred in both samples with similar relative intensities ( 5). From these results, we conclude that the isolated compound is thebaine. The first ir peak at step 3 ( Fig. 2) was also purified by RP18 and ion-exchange columns using different solvent systems (see ref. 6 ), resulting in the isolation of codeine (total, 64 pmol) and a trace of morphine.
DISCUSSION
In this paper we report the presence of the alkaloid thebaine in mammalian tissue. In addition to serving as an intermediate in the synthesis of codeine and morphine (1, 6) , thebaine may also exert some distinct physiological effect of its own.
Higher concentrations of codeine and morphine can be detected in tissues after boiling and acid hydrolysis with 10% HCl, since these alkaloids exist in a conjugated form or bound to protein (3) . As thebaine is unstable under acid hydrolysis, this procedure was omitted. The codeine and morphine isolated in this study were probably free in tissue. Thebaine can bind to plasma protein and albumin (9); therefore, it is possible that thebaine might exist in tissue bound to proteins.
In the poppy plant, Papaver somniferum, the morphinetype alkaloid thebaine is biosynthesized from two molecules of L-tyrosine (10) by way of several intermediates, such as norcoclaurine, coclaurine (11, 12) , reticuline (13) , and salutaridine (14) . It has recently been shown that norcoclaurine and coclaurine are true precursors of reticuline and thebaine (11, 12) , though tetrahydropapaveroline (THP, norlaudanosoline) had long been assumed to be the precursor (15, 16) . The possible role of THP as a precursor in the biosynthesis of morphine in mammals is unclear. THP, which is formed by the condensation between dopamine and an aldehyde derived from a second dopamine molecule (17) , has been identified in the brain of rats receiving L-3,4,-dihydroxyphenylalanine (L-dopa) (18) as well as in the urine of parkinsonian patients who have been given L-dopa (19) . However, it has not been detected in normal mammalian tissue nor has it been shown to be a precursor for reticuline in mammalian tissue. In plants (20) morphine is formed from thebaine by way of two pathways: (i) from codeine or (it) from oripavine. In mammalian tissue it has been shown that salutaridine can be formed from reticuline (5) and that the concentration of morphine and codeine increased following administration of thebaine or salutaridine (1) . The possibility that the thebaine found in the ovine brain is of a dietary origin cannot be excluded since the brain was obtained from a slaughterhouse and we were unable to test for the presence of thebaine in the food. However, we have recently shown that microsomes from various mammalian tissues in the presence of cofactors can convert thebaine to morphine; the biosynthetic pathway was similar to that that exists in plants (6) .
Therefore, the presence of thebaine as well as codeine and morphine in ovine brain provides strong evidence that morphine and codeine, which had been identified in mammals, are of endogenous origin and biosynthesized from the precursor in mammalian tissue.
Thebaine exerts profound physiological and pharmacological effects. It has slight analgesic and depressant effects and does not elicit physical dependence (21, 22) . However, thebaine can stimulate the central nervous system and cause convulsions (21) (22) (23) (24) (25) . Morphine and codeine also produce convulsion but only at high doses (21, 23, 26) , whereas at low doses, morphine can exert an anticonvulsant action (26) . Thebaine can reverse some of the effects of morphine (27, 28) . Electrophysiological studies indicate that the spasmodic effect of thebaine was different from that of morphine and codeine but was similar to that of strychnine (29) . Thebaine has been shown to inhibit binding to the glycine receptor and the -y-aminobutyric acid receptor (30) . Both receptors seem to be involved in the convulsive properties of the opiates (31, 32) . The finding of endogenous thebaine in mammalian brain
